DPhil Research Opportunities
The Radcliffe Department of Medicine is now open to applications for entry in October 2025. Research opportunities will continue to be added over the next few weeks so please continue to check for new opportunities.
| Title | |
|---|---|
| Reader Group: How do protein making factories prevent cardiovascular disease? Reader Group: How do protein making factories prevent cardiovascular disease? | John Reader |
| Watkins Group: Various relating to inherited heart muscle disease Watkins Group: Various relating to inherited heart muscle disease | Hugh Watkins |
| Zhang Group: Generative Artificial Intelligence for Cardiovascular Imaging Zhang Group: Generative Artificial Intelligence for Cardiovascular Imaging | Qiang Zhang |
| Vyas Group: Mechanisms of genomic and epigenomic instability in TP53 mutant AML Vyas Group: Mechanisms of genomic and epigenomic instability in TP53 mutant AML | Paresh Vyas |
| Vyas Group: New Immune Therapies For Acute Myeloid Leukaemia (AML) And Myeloid Blood Cancers Vyas Group: New Immune Therapies For Acute Myeloid Leukaemia (AML) And Myeloid Blood Cancers | Paresh Vyas |
| Bhattacharya Group: Targeting chemokine-driven inflammation in atherosclerosis Bhattacharya Group: Targeting chemokine-driven inflammation in atherosclerosis | Shoumo Bhattacharya |
| Akbar Group: Generating extracellular vesicles for therapeutic Immunomodulation and building tools to determine their diagnostic potential Akbar Group: Generating extracellular vesicles for therapeutic Immunomodulation and building tools to determine their diagnostic potential | Naveed Akbar |
| Chapman Group: Homologous recombination in genome maintenance and cancer prevention Chapman Group: Homologous recombination in genome maintenance and cancer prevention | Ross Chapman |
| Christodoulides Group: Deciphering the role of white and brown adipocytes in cardiometabolic diseases Christodoulides Group: Deciphering the role of white and brown adipocytes in cardiometabolic diseases | Constantinos Christodoulides |
| Drakesmith Group: Using iron to control immune responses Drakesmith Group: Using iron to control immune responses | Hal Drakesmith |
| Goriely Group: Investigating the role of genetic mosaicism in congenital disease Goriely Group: Investigating the role of genetic mosaicism in congenital disease | Anne Goriely |
| Grist Group: Translating across scales: combining clinical imaging and neuropathology to understand Multiple Sclerosis. Grist Group: Translating across scales: combining clinical imaging and neuropathology to understand Multiple Sclerosis. | James Grist |
| Kini: Personalised therapeutic interventions in genetic epilepsies: clinical and molecular approaches Kini: Personalised therapeutic interventions in genetic epilepsies: clinical and molecular approaches | Usha Kini |
| Koohy Group: Applications of multi-omics and AI to decode T cell recognition code in time and space Koohy Group: Applications of multi-omics and AI to decode T cell recognition code in time and space | Hashem Koohy |
| Lewis Group: Imaging mitochondrial trafficking and dynamics in the failing heart Lewis Group: Imaging mitochondrial trafficking and dynamics in the failing heart | Andrew Lewis |
| Mead Group: Gene-Environment Initiated Disease Progression in Myeloproliferative Neoplasms Mead Group: Gene-Environment Initiated Disease Progression in Myeloproliferative Neoplasms | Adam Mead |
| Nasteska Group: Islet protein synthesis dynamics in health and type 2 diabetes Nasteska Group: Islet protein synthesis dynamics in health and type 2 diabetes | Daniela Nasteska |
| Nerlov Group: Single Cell Biology and Genetics of Hematopoietic Stem- and Progenitor cells in Blood Cancer and Ageing Nerlov Group: Single Cell Biology and Genetics of Hematopoietic Stem- and Progenitor cells in Blood Cancer and Ageing | Claus Nerlov |
| Tyler Group: Development and Application of Hyperpolarized Magnetic Resonance Imaging in the Study of the Diseased Heart Tyler Group: Development and Application of Hyperpolarized Magnetic Resonance Imaging in the Study of the Diseased Heart | Damian Tyler |
| Tzima Group: Can we harness novel therapeutics to inhibit inflammation and cardiovascular disease? Tzima Group: Can we harness novel therapeutics to inhibit inflammation and cardiovascular disease? | Ellie Tzima |
| Reilly Group: Adverse myocardial remodelling in cardiac fibrosis and atrial fibrillation. Reilly Group: Adverse myocardial remodelling in cardiac fibrosis and atrial fibrillation. | Svetlana Reilly |
| Davies Group: Genomics and Genome Editing Davies Group: Genomics and Genome Editing | James Davies |
| Twigg Group: Building the skull – normal and abnormal development Twigg Group: Building the skull – normal and abnormal development | Stephen Twigg |
| Valkovic Group: Non-invasive cardiac metabolism assessment using ultra-high field (7T) MR Spectroscopy Valkovic Group: Non-invasive cardiac metabolism assessment using ultra-high field (7T) MR Spectroscopy | Ladislav Valkovic |
| Leeson Group: Imaging in Preventive Cardiology Research Leeson Group: Imaging in Preventive Cardiology Research | Paul Leeson |